Finebiotics Pharma Profile
Key Indicators
- Authorised Capital ₹ 11.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 11.50 Cr
as on 16-11-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.53 Cr
as on 16-11-2024
- Satisfied Charges ₹ 10.82 Cr
as on 16-11-2024
- Revenue -17.19%
(FY 2023)
- Profit -2708.30%
(FY 2023)
- Ebitda -329.11%
(FY 2023)
- Net Worth -22.65%
(FY 2023)
- Total Assets -37.50%
(FY 2023)
About Finebiotics Pharma
The Corporate was formerly known as Pharland Health Care Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 11.50 Cr and a paid-up capital of Rs 11.50 Cr.
The company currently has active open charges totaling ₹3.53 Cr. The company has closed loans amounting to ₹10.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Finebiotics Pharma Limited India are Sejal Bhatia as COMPANY SECRETARY and Rohan Seth as Cfo. Mukesh Agarwal, Vivek Rajgarhia, Parshva Jhaveri, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24231GJ2004PLC044581
- Company No.
044581
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2004
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Finebiotics Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sejal Bhatia | Company Secretary | 01-Feb-2018 | Current |
| Rohan Seth | CFO | 19-May-2017 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradipbhai Shah  | Director | 16-Aug-2012 | Current |
| Mayank Kedia | Director | 01-Jul-2020 | Current |
| Mukesh Agarwal | Director | 14-Jun-2017 | Current |
| Vivek Rajgarhia | Director | 16-Aug-2012 | Current |
| Parshva Jhaveri | Director | 17-Dec-2020 | Current |
| Vedprakash Agarwal | Whole-Time Director | 16-Aug-2012 | Current |
Financial Performance of Finebiotics Pharma.
Finebiotics Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.19% decrease. The company also saw a substantial fall in profitability, with a 2708.3% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Finebiotics Pharma?
In 2023, Finebiotics Pharma had a promoter holding of 79.87% and a public holding of 20.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Finecure Pharmaceuticals LimitedActive 19 years 9 monthsMukesh Agarwal and Vivek Rajgarhia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Sep 2023 | ₹3.00 Cr | Open |
Others Creation Date: 15 Apr 2021 | ₹2.32 M | Open |
Others Creation Date: 15 Apr 2021 | ₹1.39 M | Open |
How Many Employees Work at Finebiotics Pharma?
Finebiotics Pharma has a workforce of 46 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Finebiotics Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finebiotics Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
